Kala Pharmaceuticals, Inc (KALA)

Etorro trading 970x250
Kala Pharmaceuticals, Inc (KALA) Logo

About Kala Pharmaceuticals, Inc

Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The company’s product candidates include EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development programs comprise KPI-285/KPI-286, a receptor tyrosine kinase inhibitor program for the treatment of various retinal diseases; SEGRM program, a novel class of compounds designed to regulate gene expression through the transrepression pathway while avoiding the transactivation pathway; and surface targeted steroid program (KPI-333), a new chemical entity as a topical steroid that targets the ocular surface. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts. Address: 490 Arsenal Way, Watertown, MA, United States, 02472

Kala Pharmaceuticals, Inc News and around…

Latest news about Kala Pharmaceuticals, Inc (KALA) common stock and company :

Best Penny Stocks To Buy Now For A Short Squeeze? 5 To Watch
30 Nov, 2021 FinancialContent
12 Health Care Stocks Moving In Friday's After-Market Session
19 Nov, 2021 FinancialContent

Gainers CASI Pharmaceuticals (NASDAQ:CASI) shares moved upwards by 19.02% to $1.11 during Friday's after-market session. ...

Kala Pharma Acquires Ocular Surface Disease-Focused Company
15 Nov, 2021 FinancialContent

Kala Pharmaceuticals Inc(NASDAQ: KALA)has acquiredCombangio Inc, a private company developing regenerative ...

Kala Pharmaceuticals (KALA) Reports Q3 Loss, Misses Revenue Estimates
15 Nov, 2021 Yahoo! Finance

Kala Pharma (KALA) delivered earnings and revenue surprises of 4.44% and -40.77%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Best Penny Stocks To Buy? 5 Short Squeeze Stocks To Watch Now
15 Nov, 2021 FinancialContent
Kala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
15 Nov, 2021 Yahoo! Finance

-- Achieved $3.1 Million in Net Revenue in 3Q 2021 ---- EYSUVIS® Prescriptions Increased by 19% Compared to 2Q 2021-- Expanding Clinical-Stage Pipeline Through Acquisition of Combangio ---- Conference Call and Webcast at 10:30 a.m. ET -- WATERTOWN, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported

Kala Pharmaceuticals Acquires Combangio, Expanding its Pipeline with a Clinical-Stage Novel Biologic for the Treatment of Persistent Corneal Epithelial Defect (PCED) and other Rare Ocular Surface Diseases
15 Nov, 2021 Yahoo! Finance

-- KPI-012 is a novel secretome with a multifactorial mechanism of action for development in PCED and other orphan ocular surface diseases driven by impaired corneal healing ---- KPI-012 demonstrated positive safety and efficacy results in PCED Phase 1b clinical trial ---- Kala expects to initiate Phase 2/3 trial in 3Q 2022 ----Mark S. Blumenkranz, M.D., Professor Emeritus in the Department of Ophthalmology at Stanford University, appointed to Kala’s Board of Directors ---- Management to host co

Kala Pharmaceuticals Announces Time Change for Third Quarter 2021 Financial Results Conference Call
15 Nov, 2021 Yahoo! Finance

WATERTOWN, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it has changed the time of its previously scheduled financial results conference call and live audio webcast. The Company will now report its third quarter 2021 financial results and provide a business update on Monday, November 15

Earnings Scheduled For November 15, 2021
15 Nov, 2021 FinancialContent

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third ...

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
14 Nov, 2021 FinancialContent

Biotech stocks declined for the second straight week amid a broader market pullback, along withearnings news from small- and ...

A Preview Of Kala Pharmaceuticals's Earnings
12 Nov, 2021 FinancialContent

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors ...

Kala Pharmaceuticals to Participate in Upcoming Investor Conferences in November 2021
11 Nov, 2021 Yahoo! Finance

WATERTOWN, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that management will participate in the following virtual healthcare investor conferences in November 2021: Jefferies London Healthcare ConferenceA pre-recorded fireside chat will be made available on the company’s website beginning Thu

Kala Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference Call
08 Nov, 2021 Yahoo! Finance

WATERTOWN, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report third quarter 2021 financial results on Monday, November 15, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:30 a.m. ET. The dial-in num

Best Penny Stocks To Buy Now? 5 To Watch Before Next Week
04 Nov, 2021 FinancialContent
4 Top Penny Stocks To Watch After FOMC Meeting In November
03 Nov, 2021 FinancialContent
Best Penny Stocks To Buy For A Short Squeeze? 10 To Watch Today
01 Nov, 2021 FinancialContent
46 Biggest Movers From Yesterday
19 Oct, 2021 FinancialContent

Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both ...

12 Health Care Stocks Moving In Monday's Intraday Session
18 Oct, 2021 FinancialContent

Gainers Progenity (NASDAQ:PROG) shares increased by 33.17% to $2.85 during Monday's regular session. As of 12:30 ...

34 Stocks Moving In Monday's Mid-Day Session
18 Oct, 2021 FinancialContent

Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints ...

Kala Pharmaceuticals Announces Appointment of C. Daniel Myers to Board of Directors
18 Oct, 2021 Yahoo! Finance

WATERTOWN, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced the appointment of C. Daniel Myers to its Board of Directors. Mr. Myers, who has more than 35 years of ophthalmic pharmaceutical experience, will serve as a Class III director, and join both the Compensation and Nominating and Corporate

First Week of December 17th Options Trading For Kala Pharmaceuticals (KALA)
15 Oct, 2021 FinancialContent

Investors in Kala Pharmaceuticals Inc (KALA) saw new options become available this week, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the KALA options chain for the new December 17th contracts and identified the following call contract of particular interest.

12 Health Care Stocks Moving In Friday's Intraday Session
15 Oct, 2021 FinancialContent

Gainers Statera BioPharma (NASDAQ:STAB) shares rose 16.9% to $3.32 during Friday's regular session. The market value ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
15 Oct, 2021 FinancialContent

Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares moved upwards by 29.96% to $7.72 during Friday's pre-market ...

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

How Much Of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Do Institutions Own?
07 Oct, 2021 Yahoo! Finance

The big shareholder groups in Kala Pharmaceuticals, Inc. ( NASDAQ:KALA ) have power over the company. Institutions will...

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
05 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
01 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

Kala Pharmaceuticals, Inc (KALA) is a NASDAQ Common Stock listed in , ,

970x250